A Phase I Dose-Escalation Study Of Intraperitoneal (Ip) Cisplatin, Iv/Ip Paclitaxel, Iv Bevacizumab, And Oral Olaparib For Newly Diagnosed Adenxal Carcinoma.
JOURNAL OF CLINICAL ONCOLOGY(2017)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2017)